Evidence map›Paper›PMID 19207724›Full record

ArticleClinical and experimental pharmacology & physiology2009

Obesity induced renal oxidative stress contributes to renal injury in salt-sensitive hypertension.

Jeffrey E Quigley, Ahmed A Elmarakby, Sarah F Knight, Marlina M Manhiani, David W Stepp, Jeffrey J Olearzcyk, John D Imig

Open access · greenAbstract readComparative Study
In one paragraph

Article in Clinical and experimental pharmacology & physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jeffrey E QuigleyVascular Biology Center, Medical College of Georgia, Augusta, Georgia, USA.
Ahmed A Elmarakby
Sarah F Knight
Marlina M Manhiani
David W Stepp
Jeffrey J Olearzcyk
John D Imig
Center for Vascular Biology Research · USAugusta University · USMedical College of Wisconsin · US

Funding

Vascular Rho-kinase Signaling in Angiotensin II hypertenP01HL074167 · NHLBI · MEDICAL COLLEGE OF GEORGIA (MCG) · PI BRANDS, MICHAEL W. · 2004 to 2008
$10.5M
OXYGENASE METABOLITES AND RENAL VASCULAR ACTIVITYR01HL059699 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI IMIG, JOHN D · 1999 to 2011
$3.0M
Metabolic Determinants of Cardiovascular Dysfunction in ObesityR01HL092446 · NHLBI · AUGUSTA UNIVERSITY · PI FULTON, DAVID J, STEPP, DAVID W · 2009 to 2013
$2.1M
NHLBI NIH HHS P01 HL074167NHLBI NIH HHS R01 HL059699
6 · The paper itself

Abstract

1. In the present study, we determined the role of hypertension, oxidative stress and inflammation on kidney damage in a rodent model of obesity and diabetes. Hypertension was induced in male obese (db/db) mice and lean (db/m) mice by implantation of deoxycorticosterone acetate (DOCA) pellets and mice were allowed to drink water containing 1% salt. Mice were divided into six groups as follows: obese and lean control, obese and lean 1% salt (salt) and obese and lean DOCA plus 1% salt (DOCA-salt). 2. Blood pressure was significantly increased in lean and obese DOCA-salt groups relative to their respective controls; however, there was no difference in blood pressure between the lean and obese control and salt groups. Urinary 8-isoprostane was increased in obese control compared with lean control mice (1464 +/- 267 vs 493 +/- 53 pg/micromol creatinine, respectively) and this elevation was further increased in the obese DOCA-salt treated mice (2430 +/- 312 pg/micromol creatinine). Urinary monocyte chemoattractant protein-1 excretion and CD68-positive cells were also increased in both obese and lean DOCA-salt groups compared with their respective controls. Furthermore, DOCA-salt treatment increased collagen IV excretion in both obese and lean mice compared with controls, but there was no difference between obese and lean DOCA-salt groups. Urinary albumin excretion was significantly increased in the obese compared with the lean DOCA-salt mice (507 +/- 160 vs 202 +/- 48 microg/day, respectively). 3. These data suggest that obese DOCA-salt hypertensive mice exhibit greater renal injury than lean DOCA-salt hypertensive mice in a manner independent of blood pressure and that this renal injury is associated with obesity related pre-existing renal oxidative stress.

Indexed as

AnimalsBlood PressureDesoxycorticosteroneHypertensionKidney DiseasesMaleMiceMice, Inbred C57BLMice, ObeseObesityOxidative StressPotassium, DietarySodium Chloride, DietaryDesoxycorticosteronePotassium, DietarySodium Chloride, Dietary

Identifiers

PMID19207724
PMCPMC2710419
OpenAlexW1976646377

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.